Rank: Old Salt
Groups: Member
Joined: 9/7/2007
Posts: 2,626
Location: Harbor Area
|
Flu Shot Disabled Beautiful Cheerleader - ( Dystonia Disorder)The FDA's website lists mercury, squalene and formaldehyde among some of the ingredients in the swine flu H1N1 shot. Update: Desiree Jenning's has received chelation treatments to detox the mercury from her blood. Her symptoms have greatly improved since the treatments. (Note: I do not necessarily condone chelation treatments. I just needed to provide an update on where she is in treating her Dystonia.) Click on this link to find out about what scientists have found about mercury's (aka thimerosal) damaging effects on the brain: http://www.youtube.com/watch?v=5UT7_S... ..Research the ingredients yourself. There is a program preventing all lawsuits due to vaccine injury. Anyone who has been injured cannot sue.Although Dystonia is a less prevalant disorder, autism rates in America's children have skyrocketed. 1 in 150 children in America are diagnosed with autism. Mercury has been proven to cause nonsocial and uncontrollable behavior in primates. Scientific studies has proven mercury poisoning causes neurological damage. Dystonia is a neurological movement disorder in which sustained muscle contractions cause twisting and repetitive movements or abnormal postures.[1] The disorder may be caused by other factors such as infection, poisoning (e.g. lead poisoning) or reaction to drugs, particularly neuroleptics or can be hereditary. Long term testing on the possible side effects of the H1N1/ swine flu shot has not been done. The h1n1 swine flu shots are being given out freely in schools in America. Always research the ingredients of vaccines before you make your decision.
“The greatest sins are the sins of silence in the face of evil. The action of a prophet is not to prophesy an event that can’t be changed. It’s to prophesy pathways and timelines that you can then decide because you are co-creators of your own future. By bringing these things to light is not to bring terror to the people, but to bring control, to bring a sense of empowerment to everyone who reads this.”
|
Rank: Old Salt
Groups: Member
Joined: 9/7/2007
Posts: 2,626
Location: Harbor Area
|
http://www.treehugger.com/files/2009/12/flu-vaccine-derived--army-worm-cells-instead-whole-chicken-eggs.phpFlu Vaccine Derived From Army Worm Cells Instead Of Whole Chicken Eggsby John Laumer, Philadelphia on 12. 5.09
Business & Politics (news) Most people probably don't realize how flu vaccines are made - by injecting live flu virus into living chicken eggs, incubating the virus-infected eggs, etc. That 50-year old vaccine making process poses a potential risk to employees working with live virus, and also may offend animal rights activists. (Do PETA members accept flu vaccines; just wondering?) Could also be off-putting to persons for whom a very strict vegetarian diet is part of their religious practice. 'Who cares as long as I can get my seasonal flu vaccine on time' you may be thinking.
Should an avian (chicken) flu epidemic occur, it could wipe out chickens and block human vaccine production. (The egg method takes months, as it is.) Hence, it is of some interest that Protein Sciences is working on a method of producing flu vaccines from army caterpillars (pictured).
The "green" connection
No matter how superficially repulsive, how obscure, or how economically destructive a "pest" insect seems, its presence on Earth may benefit us. Scientists tend to frame this idea as 'needing to conserve biodiversity.' My Grandma often said "God works in strange ways" when I resisted improbable, changed circumstances.. Looking back on it, that was her polite way of saying 'deal with it kid.' A bit of wisdom that still applies, even if it makes me feel all crawly after the inoculation.
Technology Review has the details in Caterpillar Flu Vaccine Delayed; The FDA wants further evidence that the novel approach is completely safe.
Today's egg-based vaccine technology is slow and unwieldy, requiring at least six months' of production time and millions of eggs to supply enough doses for a regular flu season. If a new virus appears unexpectedly, the antiquated system wouldn't be able to gear up fast enough to produce a new vaccine, many experts agree. What's more, if the virus itself were derived from birds, it might reduce the supply of eggs, hampering the country's main means of vaccine production.
For the past decade, Protein Sciences, along with a number of other companies, has been looking to cell-based vaccines as a more efficient and robust alternative. Instead of growing viruses in chicken eggs, researchers inject virus strains into insect cells. Both the virus and the cells then grow and multiply quickly in bioreactors. Scientists break the cell walls and harvest a key protein, called hemagglutinin, produced by the virus. This protein, found on the influenza virus's outer surface, is responsible for binding to cells in the body, causing a viral infection. Scientists purify and inactivate the harvested protein so that it can stimulate an immune response without causing an infection. The protein is the main ingredient in a vaccine.
Protein Sciences' technology is a slight variation on the conventional cell-based approach. Instead of growing live viruses, the company replicates viral DNA within cells. The genes for hemagglutinin are extracted from a dead flu virus and injected into baculovirus--a virus that infects a caterpillar called the armyworm. The baculovirus is then injected into ovary cells isolated from the armyworm. In a bioreactor, the virus eats away at cells, replicating DNA and producing hemagglutinin.
“The greatest sins are the sins of silence in the face of evil. The action of a prophet is not to prophesy an event that can’t be changed. It’s to prophesy pathways and timelines that you can then decide because you are co-creators of your own future. By bringing these things to light is not to bring terror to the people, but to bring control, to bring a sense of empowerment to everyone who reads this.”
|
Rank: Old Salt
Groups: Member
Joined: 9/7/2007
Posts: 2,626
Location: Harbor Area
|
i'm telling ya - they gonna give you the crazies if you don't watch out! http://www.technologyreview.com/biomedicine/24031/Caterpillar Flu Vaccine DelayedThe FDA wants further evidence that the novel approach is completely safe.By Jennifer ChuA new method of making flu vaccines is faster, more efficient, and more robust than the one that has been in use for the last 50 years. It has the potential to scale up rapidly, to deal with new strains of influenza such as this year's H1N1, and to help stem a pandemic tide. However, a U.S. Food and Drug Administration advisory panel voted in late November not to approve the technology, which involves growing key vaccine ingredients inside caterpillar cells instead of in chicken eggs, as is currently done. The FDA says that the company behind the new approach, Protein Sciences, based in Meriden, CT, needs to test it further before the method can be approved for use in the United States.
Jose Romero, chief of pediatric disease at Arkansas Children's Hospital and a member of the 11-person FDA panel, says that, while the company has more to do in order to prove safety, the cell-based technology shows considerable promise.
"This type of technology is going to move traditional influenza vaccinology into the 21st century," says Romero. "We recognize that there may come a day when a strain does arrive that cannot be supported by growth in traditional egg-based technology, and this and other cell-based technologies can breach that problem and provide us with another avenue for developing vaccines."
Today's egg-based vaccine technology is slow and unwieldy, requiring at least six months' of production time and millions of eggs to supply enough doses for a regular flu season. If a new virus appears unexpectedly, the antiquated system wouldn't be able to gear up fast enough to produce a new vaccine, many experts agree. What's more, if the virus itself were derived from birds, it might reduce the supply of eggs, hampering the country's main means of vaccine production.
For the past decade, Protein Sciences, along with a number of other companies, has been looking to cell-based vaccines as a more efficient and robust alternative. Instead of growing viruses in chicken eggs, researchers inject virus strains into insect cells. Both the virus and the cells then grow and multiply quickly in bioreactors. Scientists break the cell walls and harvest a key protein, called hemagglutinin, produced by the virus. This protein, found on the influenza virus's outer surface, is responsible for binding to cells in the body, causing a viral infection. Scientists purify and inactivate the harvested protein so that it can stimulate an immune response without causing an infection. The protein is the main ingredient in a vaccine.
Protein Sciences' technology, which is twice as fast as the egg-based approach, is a slight variation on the conventional cell-based approach. Instead of growing live viruses, the company replicates viral DNA within cells. The genes for hemagglutinin are extracted from a dead flu virus and injected into baculovirus--a virus that infects a caterpillar called the armyworm. The baculovirus is then injected into ovary cells isolated from the armyworm. In a bioreactor, the virus eats away at cells, replicating DNA and producing hemagglutinin.
"Because the starting material is a DNA sequence, it eliminates a lot of steps you have to go through, because the flu virus itself is not part of this production process," says John Treanor, a medical advisor to the company and professor of microbiology and immunology at the University of Rochester Medical Center in New York. "You also don't have concerns of workers getting infected, versus using a growing virus."
Treanor headed four clinical trials to test the vaccine for effectiveness against seasonal flu. The trials compared the effects of the company's vaccine against a conventional one in 3,231 people aged 18 and older.
The company presented its results to the FDA advisory board. While the new vaccine was found to protect against seasonal flu symptoms in those 18 to 49, it was not possible to draw significant conclusions for older participants. Several older subjects suffered from facial swelling after receiving the vaccine, and one developed a temporary paralysis on one side of the face. This might have been a preexisting condition, but researchers couldn't be sure if the condition was independent of the vaccine. "When you have one case, it's hard to know," says Treanor.
The FDA panel recommended that the company expand the patient group to determine whether the vaccine is safe in a larger, older population.
Other companies seeking FDA approval for similar cell-based vaccines include Novartis, which opened a vaccine manufacturing plant in North Carolina this week and plans to produce vaccines from dog kidney cells.
FluGen, a vaccine company based in Madison, WI, has also entered the race. It is growing flu virus in manipulated hamster ovary cells--a cell line that has already been approved by the FDA for producing drugs to treat rheumatoid arthritis. FluGen is a little behind its bigger competitors, but CEO Paul Radspinner says he will take a lesson from Protein Sciences' experience when it comes time to seek FDA approval. "Maybe it's a learning point," says Radspinner. "We'll be very careful with where we go with clinical trials where there's a database of patients coming through, and [make sure] that preexisting conditions are being noted."
“The greatest sins are the sins of silence in the face of evil. The action of a prophet is not to prophesy an event that can’t be changed. It’s to prophesy pathways and timelines that you can then decide because you are co-creators of your own future. By bringing these things to light is not to bring terror to the people, but to bring control, to bring a sense of empowerment to everyone who reads this.”
|
